A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster, Lancet (Lond. Engl.), vol.2020, pp.514-523 ,
An interactive web-based dashboard to track COVID-19 in real time, Lancet Infect. Dis, vol.20, pp.533-534, 2020. ,
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study, Lancet (Lond. Engl.), vol.2020, pp.507-513 ,
, Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in, vol.2020
SARS-CoV-2 and COVID-19: Facing the pandemic together as citizens and cardiovascular practitioners. Minerva Cardioangiol, 2020. ,
CSC Expert Consensus on Principles of Clinical Management of Patients with Severe Emergent Cardiovascular Diseases during the COVID-19 Epidemic, Circulation, 2020. ,
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study, Lancet ,
, Clinical features of patients infected with 2019 novel coronavirus in, vol.2020, pp.497-506
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China, JAMA Cardiol, 2020. ,
A Novel Coronavirus from Patients with Pneumonia in China, New Engl. J. Med, vol.382, pp.727-733, 2019. ,
, Genetic Recombination, and Pathogenesis of Coronaviruses, vol.24, pp.490-502, 2016.
Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic, J. Am. Coll. Cardiol, 2020. ,
Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding, Lancet (Lond. Engl.), vol.2020, pp.565-574 ,
, Guidance for Risk Assessment and Public Health Management of Healthcare Personnel with Potential Exposure in a Healthcare Setting to Patients with Coronavirus Disease (COVID-19), p.25, 2020.
Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor, Nature, vol.503, pp.535-538, 2013. ,
A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, vol.579, pp.270-273, 2020. ,
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor, Cell, vol.181, pp.271-280, 2020. ,
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target ,
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa, Int. J. Oral Sci, vol.12, 2020. ,
Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China, Clin. Res. Cardiol. Off. J. Ger. Card. Soc, 2020. ,
Modeling influenza epidemics and pandemics: Insights into the future of swine flu (H1N1), BMC Med, vol.7, p.30, 2009. ,
Middle East respiratory syndrome, Lancet (Lond. Engl.), vol.386, pp.995-1007, 2015. ,
Another Decade, Another Coronavirus, N. Engl. J. Med, vol.2020, pp.760-762 ,
Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, vol.25, 2020. ,
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients, N. Engl. J. Med, vol.382, pp.1177-1179, 2020. ,
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: A prospective study, Lancet (Lond. Engl.), vol.361, pp.1767-1772, 2003. ,
Clinical Characteristics of Coronavirus Disease 2019 in China, N. Engl. J. Med, vol.382, pp.1708-1720, 2020. ,
The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application, Ann. Intern. Med, 2020. ,
Self-reported olfactory and taste disorders in SARS-CoV-2 patients: A cross-sectional study, Clin. Infect. Dis, 2020. ,
The Variety of Cardiovascular Presentations of COVID-19, Circulation, 2020. ,
ST-Segment Elevation in Patients with Covid-19-A Case Series, N. Engl. J. Med, 2020. ,
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention, vol.2020 ,
Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy, JAMA, 2020. ,
, Clinical Characteristics of Covid, vol.19, 2020.
Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease, vol.2020 ,
Obesity a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms, Circulation, 2020. ,
Treatment for severe acute respiratory distress syndrome from COVID-19, Lancet Respir. Med, 2020. ,
Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics, JAMA, 2020. ,
Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases, Lancet Respir. Med, 2020. ,
Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area, JAMA, vol.289, pp.2801-2809, 2003. ,
Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): A systematic review and meta-analysis, Int. J. Infect. Dis. IJID Off. Publ. Int. Soc. Infect. Dis, vol.49, pp.129-133, 2016. ,
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease, 2019. ,
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensiv. Care Med, 2020. ,
COVID-19) and Cardiovascular Disease, Coronavirus Disease, 2019. ,
Aging of the Immune System. Mechanisms and Therapeutic Targets, Ann. Am. Thorac. Soc, vol.13, pp.422-428, 2016. ,
Tuberculosis and diabetes mellitus: Convergence of two epidemics, Lancet Infect. Dis, vol.9, pp.737-746, 2009. ,
Influenza vaccination in patients with heart failure: A systematic review and meta-analysis of observational studies, Heart (Br. Card. Soc, vol.2020, pp.350-357 ,
The association of influenza infection and vaccine with myocardial infarction: Systematic review and meta-analysis of self-controlled case series, Expert Rev. Vaccines, vol.18, pp.1211-1217, 2019. ,
Of birds and men: cardiologists' role in influenza pandemics, Lancet (Lond. Engl, vol.364, 1309. ,
Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State, 2020. ,
, Patient With Coronavirus Disease, 2019.
SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS, Eur. J. Clin. Investig, vol.39, pp.618-625, 2009. ,
Acute myocarditis associated with novel Middle east respiratory syndrome coronavirus, Ann. Saudi Med, vol.36, pp.78-80, 2016. ,
Clinical and radiographic features of cardiac injury in patients with 2019 novel coronavirus pneumonia, vol.2020 ,
Coronaviruses and the cardiovascular system: Acute and long-term implications, Eur. Heart J, 2020. ,
Myocardial localization of coronavirus in COVID-19 cardiogenic shock, Eur. J. Heart Fail, 2020. ,
Typical takotsubo syndrome triggered by SARS-CoV-2 infection, Eur. Heart J, 2020. ,
Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin, Eur. Heart J, 2020. ,
First Case of COVID-19 Infection with Fulminant Myocarditis Complication: Case Report and Insights, 2020. ,
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection, N. Engl. J. Med, vol.378, pp.345-353, 2018. ,
, Fourth Universal Definition of Myocardial Infarction, vol.72, pp.2231-2264, 2018.
Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome, Circulation, 2020. ,
Troponin and BNP Use in COVID-19, p.25, 2020. ,
COVID-19-related myocarditis in a 21-year-old female patient, Eur. Heart J, 2020. ,
, Clinical Management of Severe Acute Respiratory Infection When COVID-19 is Suspected, p.25, 2020.
Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus, Ann. Intensiv. Care, vol.8, issue.3, 2018. ,
Effect of High Influenza Activity on Risk of Ventricular Arrhythmias Requiring Therapy in Patients With Implantable Cardiac Defibrillators and Cardiac Resynchronization Therapy Defibrillators, Am. J. Cardiol, vol.124, pp.44-50, 2019. ,
Cardiovascular complications of severe acute respiratory syndrome, Postgrad. Med. J, vol.82, pp.140-144, 2006. ,
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia, J. Thromb. Haemost, vol.2020, pp.844-847 ,
ISTH interim guidance on recognition and management of coagulopathy in COVID-19, J. Thromb. Haemost, 2020. ,
Analysis of deaths during the severe acute respiratory syndrome (SARS) epidemic in Singapore: Challenges in determining a SARS diagnosis, Arch. Pathol. Lab. Med, vol.128, pp.195-204, 2004. ,
Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China. Ann. Oncol, 2020. ,
Acute pulmonary embolism and COVID-19 pneumonia: A random association?, Eur. Heart J, 2020. ,
COVID-19 Complicated by Acute Pulmonary Embolism, Radiol. Cardiothorac. Imaging, vol.2020, 200067. ,
Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases ,
Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections, vol.2020 ,
MERS-CoV infection is associated with downregulation of genes encoding Th1 and Th2 cytokines/chemokines and elevated inflammatory innate immune response in the lower respiratory tract, Cytokine, vol.126, 2020. ,
Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia, Emerg. Microbes Infect, vol.2020, pp.727-732 ,
Severe COVID-19 infection associated with endothelial activation, Thromb. Res, 2020. ,
Is COVID-19 an Endothelial Disease? Clinical and Basic Evidence, 2020. ,
Endothelial cell infection and endotheliitis in COVID-19, Lancet (Lond. Engl.), 2020. ,
Risk stratification in normotensive acute pulmonary embolism patients: Focus on the intermediate-high risk subgroup, Eur. Heart J. Acute Cardiovasc. Care, 2019. ,
Differences in negative T waves between acute pulmonary embolism and acute coronary syndrome, Circ. J. Off. J. Jpn. Circ. Soc, vol.78, pp.483-489, 2014. ,
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis, J. Pathol, vol.203, pp.631-637, 2004. ,
Angiotensin-converting enzyme 2 protects from severe acute lung failure, Nature, vol.436, pp.112-116, 2005. ,
COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence? JAMA 2020 ,
, Should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? Eur. Heart J. 2020
Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction, Circ. Heart Fail, vol.2, pp.446-455, 2009. ,
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19, N. Engl. J. Med, 2020. ,
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?, Lancet Respir. Med, 2020. ,
COVID-19 and the cardiovascular system, Nat. Rev. Cardiol, vol.2020, pp.259-260 ,
Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2, Circulation, vol.111, pp.2605-2610, 2005. ,
Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors, Hypertension, vol.43, pp.970-976, 1979. ,
Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker, Am. J. Hypertens, vol.28, pp.15-21, 2015. ,
Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease, PLoS ONE, vol.13, 2018. ,
Soluble angiotensin-converting enzyme 2 in human heart failure: Relation with myocardial function and clinical outcomes, J. Card. Fail, vol.15, pp.565-571, 2009. ,
Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19, Circ. Res, 2020. ,
Addresses Concerns Re: Using RAAS Antagonists in COVID-19, p.25, 2020. ,
Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers, p.25, 2020. ,
, COVID-19 and Concerns Regarding Use of ACEi/ARB/ARNi Medications for Heart Failure or Hypertension, Canadian Cardiovascular Society, p.25, 2020.
Potential Effects of Coronaviruses on the Cardiovascular System: A Review, JAMA Cardiol, 2020. ,
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19, N. Engl. J. Med, vol.382, pp.1787-1799, 2020. ,
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro, Cell Res, vol.30, pp.269-271, 2020. ,
Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial, Int. J. Antimicrob. Agents, 2020. ,
URL : https://hal.archives-ouvertes.fr/hal-02525126
Chloroquine-induced cardiomyopathy: A reversible cause of heart failure, ESC Heart Fail, vol.5, pp.372-375, 2018. ,
Chloroquine cardiomyopathy-A review of the literature, Immunopharmacol. Immunotoxicol, vol.35, pp.434-442, 2013. ,
Ventricular Arrhythmia Risk Due to Hydroxychloroquine-Azithromycin Treatment for COVID-19, p.25, 2020. ,
Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease, JAMA, vol.313, pp.264-274, 2015. ,